Product Program year 2020 Source: CMS Open Payments

Neuromodulation Dspsbls and Accs

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$3,236,823

9,527 payments

Research payments

$0

0 payments

Through program year 2020, $3,236,823 in general payments and $0 in research payments were reported against Neuromodulation Dspsbls and Accs (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $1,869,580 5,641
2019 General $1,367,243 3,886

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $3,236,823 9,527 payments
Top recipients General payments · program year 2020
  1. Timothy Deer Interventional Pain Medicine · Charleston, WV $237,641 13% · 228 payments
  2. Steven Falowski Neurological Surgery · Fountain Hill, PA $165,535 9% · 138 payments
  3. Pankaj Mehta Interventional Pain Medicine · Killeen, TX $140,005 7% · 120 payments
  4. Bradley Vilims Interventional Pain Medicine · Lakewood, CO $107,777 6% · 3 payments
  5. Jeffery Rowe Physical Medicine & Rehabilitation · King Of Prussia, PA $78,914 4% · 86 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Pain Medicine Pain Medicine $771,679 43% · 176 practitioners
  2. Pain Medicine Anesthesiology $316,453 18% · 181 practitioners
  3. Neurological Surgery $271,667 15% · 101 practitioners
  4. Neurology Psychiatry & Neurology $163,822 9% · 63 practitioners
  5. Pain Medicine Physical Medicine & Rehabilitation $97,386 5% · 58 practitioners

The top 5 of 42 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $332,414 18% · 75 recipients
  2. Pennsylvania $284,768 15% · 45 recipients
  3. West Virginia $246,222 13% · 11 recipients
  4. Texas $188,230 10% · 113 recipients
  5. Colorado $111,029 6% · 9 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

9,527 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record